Arrow Financial’s Organon & Co OGN Stock Holding History

Arrow Financial’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-336	Closed	-$6.43K	–	277
2024 Q3	$6.43K	Hold	336	–	–	﹤0.01%	305
2024 Q2	$6.96K	Buy	336 +322	+2,300%	+$6.4K	﹤0.01%	294
2024 Q1	$263	Sell	14 -3	-18%	-$51	﹤0.01%	330
2023 Q4	$245	Hold	17	–	–	﹤0.01%	344
2023 Q3	$295	Hold	17	–	–	﹤0.01%	341
2023 Q2	$354	Sell	17 -3	-15%	-$65	﹤0.01%	320
2023 Q1	$470	Sell	20 -4	-17%	-$107	﹤0.01%	320
2022 Q4	$1K	Sell	24 -156	-87%	-$3.99K	﹤0.01%	329
2022 Q3	$4K	Hold	180	–	–	﹤0.01%	317
2022 Q2	$6K	Sell	180 -10	-5%	-$350	﹤0.01%	312
2022 Q1	$6K	Buy	190 +10	+6%	+$342	﹤0.01%	317
2021 Q4	$5K	Sell	180 -112	-38%	-$3.65K	﹤0.01%	311
2021 Q3	$9K	Sell	292 -4,276	-94%	-$137K	﹤0.01%	289
2021 Q2	$137K	Buy	+4,568	New	+$150K	0.02%	178

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrow Financial's OGN Position: Q4 2024 in Review

Arrow Financial sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 336 shares — an estimated $6.43K sold.

Arrow Financial first reported a position in OGN in Q2 2021 and held it in 14 quarters. The position peaked at $137K in Q2 2021. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

Arrow Financial reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
Arrow Financial sold 336 Organon & Co shares in Q4 2024, an estimated $6.43K.
Arrow Financial first reported a position in Organon & Co in Q2 2021 and held it in 14 quarters.
Arrow Financial's Organon & Co position peaked at $137K in Q2 2021.
740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Arrow Financial's 13F filing for Q4 2024, filed 14 Feb 2025.